Abstract:Objective To investigate the clinical features, diagnosis and treatment methods as well as prognosis of neurogenic tumors in middle ear.Methods Clinical data of 8 patients with pathologically confirmed neurogenic tumors of the middle ear surgically treated in our hospital from Jan. 2010 to Mar. 2023 were retrospectively analyzed. Their initial symptoms were mainly ear discharge in 4 cases, hearing loss in 3 cases and facial paralysis in one. There were 5 cases with mass protrusion into the external auditory canal, 3 cases with tympanic tension perforation.Pure tone audiometry showed that all patients had varying degrees of hearing loss, including mixed deafness in 4 cases, conduction deafness in 3, and profound sensorineural deafness in one.Results Computerized tomography (CT) and magnetic resonance imaging (MRI) of the middle ear were completed in all patients, suggesting that the tumor involved the surface of promontory or the middle tympanum in 5 cases, and the horizontal segment of facial nerve in 3 cases with middle cranial fossa invasion in one. Modified radical mastoidectomy was performed in all the 8 patients, and the postoperative pathology confirmed tympanosoma in 4 cases, facial neurofibroma in 2 cases, facial neuroschwannoma in one and neuroendocrine adenoma in another. Two patients were diagnosed as middle ear cholesteatoma and chronic suppurative otitis media by preoperative biopsy with a preoperative pathological misdiagnosis rate of 25% (2/8). Postoperative followed up ranged from one month to 8 years revealed recurrence in none.Conclusions The incidence of neurogenic tumors in the middle ear is relatively low with different clinical manifestations and a certain misdiagnosis rate. Preoperative CT and enhanced MRI examination, as well as postoperative pathology and immunohistochemistry are helpful for definite diagnosis. Surgical treatment is an effective means to treat the disease.